Frontiers in Cellular Neuroscience,
Год журнала:
2019,
Номер
13
Опубликована: Июль 31, 2019
The
immune
system
provides
protection
in
the
CNS
via
resident
microglial
cells
and
those
that
traffic
into
it
course
of
pathological
challenges.
These
populations
are
key
players
modulating
functions
involved
disease
outcomes.
In
this
review,
we
briefly
summarize
highlight
current
state
knowledge
differential
contributions
microglia
monocytes
Alzheimer's
multiple
sclerosis.
role
innate
immunity
is
frequently
seen
as
a
Yin
Yang
both
diseases,
but
depends
on
environment,
pre-clinical
models
type
involved.
Hippocampus
is
the
significant
component
of
limbic
lobe,
which
further
subdivided
into
dentate
gyrus
and
parts
Cornu
Ammonis.
It
crucial
region
for
learning
memory;
its
sub-regions
aid
in
generation
episodic
memory.
However,
hippocampus
one
brain
areas
affected
by
Alzheimer's
(AD).
In
early
stages
AD,
shows
rapid
loss
tissue,
associated
with
functional
disconnection
other
brain.
progression
atrophy
medial
temporal
hippocampal
regions
are
structural
markers
magnetic
resonance
imaging
(MRI).
Lack
sirtuin
(SIRT)
expression
neurons
will
impair
cognitive
function,
including
recent
memory
spatial
learning.
Proliferation,
differentiation,
migrations
steps
involved
adult
neurogenesis.
The
microglia
more
immunologically
active
than
Intrinsic
factors
like
hormones,
glia,
vascular
nourishment
instrumental
neural
stem
cell
(NSC)
functions
maintaining
brain's
microenvironment.
Along
intrinsic
factors,
many
extrinsic
dietary
intake
physical
activity
may
also
influence
NSCs.
Hence,
pro-neurogenic
lifestyle
could
delay
neurodegeneration.
Frontiers in Immunology,
Год журнала:
2020,
Номер
11
Опубликована: Март 31, 2020
Neuroinflammation
commences
decades
before
Alzheimer's
disease
(AD)
clinical
onset
and
represents
one
of
the
earliest
pathomechanistic
alterations
throughout
AD
its
continuum.
Large-scale
genome-wide
association
studies
point
out
several
genetic
variants
-
TREM2,
CD33,
PILRA,
CR1,
MS4A,
CLU,
ABCA7,
EPHA1,
HLA-DRB5-HLA-DRB1
potentially
linked
to
neuroinflammation.
Most
these
genes
are
involved
in
proinflammatory
intracellular
signaling,
cytokines/interleukins
cell
turn-over,
synaptic
activity,
lipid
metabolism,
vesicle
trafficking.
Proteomic
indicate
that
a
plethora
interconnected
aberrant
molecular
pathways,
set
off
perpetuated
by
TNF-α,
TGF-β,
IL-1β,
receptor
protein
Microglia
astrocytes
key
cellular
drivers
regulators
Under
physiological
conditions,
they
important
for
neurotransmission
homeostasis.
In
AD,
there
is
turning
pathophysiological
evolution
where
glial
cells
sustain
an
overexpressed
inflammatory
response
synergizes
with
amyloid-β
tau
accumulation,
drives
synaptotoxicity
neurodegeneration
self-reinforcing
manner.
Despite
strong
therapeutic
rationale,
previous
trials
investigating
compounds
anti-inflammatory
properties,
including
non-steroidal
drugs
(NSAIDs)
did
not
achieve
primary
efficacy
endpoints.
It
conceivable
study
design
issues,
lack
diagnostic
accuracy
biomarkers
target
population
identification
proof-of-mechanism
may
partially
explain
negative
outcomes.
However,
recent
meta-analysis
indicates
potential
biological
effect
NSAIDs.
this
regard,
candidate
fluid
neuroinflammation
under
analytical/clinical
validation,
i.e.
MCP-1,
IL-6,
TNF-α
complexes,
YKL-40.
PET
radio-ligands
investigated
accomplish
in-vivo
longitudinal
regional
exploration
Biomarkers
tracking
different
pathways
(body
matrixes)
along
brain
neuroinflammatory
endophenotypes
(neuroimaging
markers),
can
untangle
temporal-spatial
dynamics
between
other
mechanisms.
Robust
biomarker-drug
co-development
pipelines
expected
enrich
large-scale
testing
new-generation
active,
directly
or
indirectly,
on
targets
displaying
putative
disease-modifying
effects:
novel
NSAIDs,
AL002
(anti-TREM2
antibody),
anti-Aβ
protofibrils
(BAN2401),
AL003
(anti-CD33
antibody).
As
next
step,
taking
advantage
breakthrough
multimodal
techniques
coupled
systems
biology
approach
path
pursue
developing
individualized
strategies
targeting
framework
precision
medicine.
International Journal of Molecular Sciences,
Год журнала:
2021,
Номер
22(18), С. 9987 - 9987
Опубликована: Сен. 15, 2021
Insulin
plays
a
range
of
roles
as
an
anabolic
hormone
in
peripheral
tissues.
It
regulates
glucose
metabolism,
stimulates
transport
into
cells
and
suppresses
hepatic
production.
influences
cell
growth,
differentiation
protein
synthesis,
inhibits
catabolic
processes
such
glycolysis,
lipolysis
proteolysis.
insulin-like
growth
factor-1
receptors
are
expressed
on
all
types
the
central
nervous
system.
Widespread
distribution
brain
confirms
that
insulin
signaling
important
diverse
this
organ.
is
known
to
regulate
support
cognition,
enhance
outgrowth
neurons,
modulate
release
uptake
catecholamine,
expression
localization
gamma-aminobutyric
acid
(GABA).
also
able
freely
cross
blood–brain
barrier
from
circulation.
In
addition,
changes
signaling,
caused
inter
alia
resistance,
may
accelerate
aging,
affect
plasticity
possibly
neurodegeneration.
There
two
significant
signal
transduction
pathways:
PBK/AKT
pathway
which
responsible
for
metabolic
effects,
MAPK
survival
gene
expression.
The
aim
study
describe
role
played
by
CNS,
both
healthy
people
those
with
pathologies
resistance
Alzheimer’s
disease.
Journal of Neurochemistry,
Год журнала:
2021,
Номер
158(3), С. 621 - 639
Опубликована: Фев. 20, 2021
There
is
growing
evidence
that
excessive
microglial
phagocytosis
of
neurons
and
synapses
contributes
to
multiple
brain
pathologies.
RNA-seq
genome-wide
association
(GWAS)
studies
have
linked
phagocytic
genes
neurodegenerative
diseases,
knock-out
has
been
found
protect
against
neurodegeneration
in
animal
models,
suggesting
neurodegeneration.
Here,
we
review
recent
live
causes
models
Alzheimer's
disease
other
tauopathies,
Parkinson's
disease,
frontotemporal
dementias,
sclerosis,
retinal
degeneration
induced
by
ischaemia,
infection
or
ageing.
We
also
factors
regulating
neurons,
including:
nucleotides,
frackalkine,
phosphatidylserine,
calreticulin,
UDP,
CD47,
sialylation,
complement,
galectin-3,
Apolipoprotein
E,
receptors,
Siglec
cytokines,
epigenetics
expression
profile.
Some
these
may
be
potential
treatment
targets
prevent
mediated
synapses.
Stem Cells Translational Medicine,
Год журнала:
2020,
Номер
9(9), С. 1068 - 1084
Опубликована: Июнь 4, 2020
The
critical
role
of
neuroinflammation
in
favoring
and
accelerating
the
pathogenic
process
Alzheimer's
disease
(AD)
increased
need
to
target
cerebral
innate
immune
cells
as
a
potential
therapeutic
strategy
slow
down
progression.
In
this
scenario,
mesenchymal
stem
(MSCs)
have
risen
considerable
interest
thanks
their
immunomodulatory
properties,
which
been
largely
ascribed
release
extracellular
vesicles
(EVs),
namely
exosomes
microvesicles.
Indeed,
beneficial
effects
MSC-EVs
regulating
inflammatory
response
reported
different
AD
mouse
models,
upon
chronic
intravenous
or
intracerebroventricular
administration.
study,
we
use
triple-transgenic
3xTg
mice
showing
for
first
time
that
intranasal
route
administration
EVs,
derived
from
cytokine-preconditioned
MSCs,
was
able
induce
neuroprotective
AD.
reached
brain,
where
they
dampened
activation
microglia
dendritic
spine
density.
polarized
vitro
murine
primary
toward
an
anti-inflammatory
phenotype
suggesting
observed
transgenic
could
result
positive
modulation
status.
possibility
administer
through
noninvasive
demonstration
efficacy
might
accelerate
chance
translational
exploitation
Alzheimer s & Dementia,
Год журнала:
2022,
Номер
18(11), С. 2327 - 2340
Опубликована: Март 2, 2022
Abstract
Objective
Evaluating
the
efficacy
of
3,6’‐dithioPomalidomide
in
5xFAD
Alzheimer's
disease
(AD)
mice
to
test
hypothesis
that
neuroinflammation
is
directly
involved
development
synaptic/neuronal
loss
and
cognitive
decline.
Background
Amyloid‐β
(Aβ)
or
tau‐focused
clinical
trials
have
proved
unsuccessful
mitigating
AD‐associated
impairment.
Identification
new
drug
targets
needed.
Neuroinflammation
a
therapeutic
target
neurodegenerative
disorders,
TNF‐α
pivotal
neuroinflammatory
driver.
New
chronic
drives
progressive
Pharmacologically
microglial/astrocyte
activation
without
altering
Aβ
generation
will
define
role
AD
progression.
Major
challenges
Difficulty
TNF‐α‐lowering
compounds
reaching
brain,
identification
therapeutic‐time
window
preserve
beneficial
processes.
Linkage
other
major
theories
Microglia/astroglia
are
heavily
implicated
maintenance
synaptic
plasticity/function
healthy
brain
disrupted
by
Aβ.
Mitigation
gliosis
can
restore
homeostasis/cognitive
function.